Is it standard of care to perform a cervical cytology (Pap) test during pregnancy if the patient has not had a Pap in the past year?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cervical Cancer Screening During Pregnancy

Yes, it is standard of care to perform cervical cytology (Pap test) during pregnancy if the patient is due for screening based on routine screening intervals, regardless of whether it has been done in the last year. 1

Key Recommendation

Pregnant women should be screened at the same frequency as nonpregnant women 1. This means:

  • Ages 21-29 years: Cytology alone every 3 years 2
  • Ages 30-65 years: Cytology plus HPV co-testing every 5 years (preferred) OR cytology alone every 3 years (acceptable) 2

Clinical Reasoning

The guideline evidence is clear and consistent across multiple CDC STD Treatment Guidelines (2010) that pregnancy does not alter the screening schedule 1. If a pregnant patient is due for routine screening based on standard intervals, the Pap test should be performed during pregnancy.

Important technical considerations:

  • Use a swab and Ayre's spatula for collection 1
  • Cytobrushes are NOT recommended in pregnancy 1
  • Liquid-based cytology is acceptable 1

Management of Abnormal Results Differs

While screening frequency remains the same, management of abnormal results is more conservative in pregnancy 2:

  • Colposcopy can be deferred until at least 6 weeks postpartum for most abnormalities 3
  • Endocervical curettage is unacceptable in pregnant women 3
  • For pregnant women with LSIL without CIN 2, postpartum management is advised 2
  • Treatment of CIN 1 is not recommended during pregnancy 2

Common Pitfalls to Avoid

  1. Do not skip screening simply because the patient is pregnant - pregnancy represents an important opportunity to screen women who may otherwise be underscreened 4, 5

  2. Be aware of pregnancy-related cytological changes that can mimic abnormalities 6:

    • Navicular cells
    • Hyperplastic endocervical cells
    • Immature metaplastic cells
    • Decidual cells or trophoblasts
    • These can mimic koilocytosis, adenocarcinoma in situ, or HSIL
  3. Do not use cytobrushes - this is explicitly contraindicated in pregnancy due to risk of bleeding and pregnancy complications 1

  4. Remember that CIN has higher regression rates during pregnancy, particularly CIN 2, with minimal progression risk 6, 7

Clinical Context

Approximately 3% of newly diagnosed cervical cancers occur in pregnant women, and up to 20% of pregnant women may have abnormal Pap results 4. The prevalence of abnormal cytology in pregnancy does not differ from age-matched nonpregnant populations 4. This makes pregnancy an opportune time for screening, especially in populations with poor screening uptake 5.

The bottom line: Follow standard screening intervals during pregnancy, but modify management of abnormal results to be more conservative, deferring invasive procedures until postpartum when feasible.

References

Guideline

sexually transmitted diseases treatment guidelines, 2010.

MMWR Recommendations and Reports, 2010

Guideline

cervical cancer screening.

Journal of the National Comprehensive Cancer Network : JNCCN, 2014

Research

Cervical cancer screening in pregnancy.

Obstetrics and gynecology clinics of North America, 2008

Research

Abnormal Pap smear among pregnant women - Feasibility of opportunistic cervical screening.

European journal of obstetrics & gynecology and reproductive biology: X, 2023

Research

Cervical intraepithelial neoplasia and cervical cytology in pregnancy.

Journal of pathology and translational medicine, 2024

Research

Abnormal pap smear and cervical cancer in pregnancy.

Clinical obstetrics and gynecology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.